Yunjie Fu

34PUBLICATIONS
120CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersInnate immunityEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Mar 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Jian-Chun Duan, Jia Zhong, Bo-Yang Sun

|Oct 24, 2025
Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies.

Yan Sun, Haochen Yang, Qing Xu

|May 16, 2025
Phase I/II Study of Tifcemalimab, an Anti-B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer.

Ying Cheng, Jie Wang, Yan Yu

|Feb 24, 2025
Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.

Jiefei Han, Yiting Dong, Xiuli Zhu

|Nov 25, 2024
Small cell lung cancer with liver metastases: from underlying mechanisms to treatment strategies.

Linjie Fan, Yiwen Lin, Yunjie Fu

|Feb 08, 2024
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.

Jiefei Han, Yiting Dong, Xiuli Zhu

Pageof 6

Frequent Collaborators

6 joint publications

Jianchun Duan

6 joint publications

Jiachen Xu

5 joint publications

Zhijie Wang

4 joint publications

Jianchun Duan